首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   339670篇
  免费   155843篇
  国内免费   29939篇
  2018年   4604篇
  2016年   5348篇
  2015年   6806篇
  2014年   7453篇
  2013年   9946篇
  2012年   10857篇
  2011年   11565篇
  2010年   10047篇
  2009年   14375篇
  2008年   11351篇
  2007年   11347篇
  2006年   9858篇
  2005年   9651篇
  2004年   9510篇
  2003年   8882篇
  2002年   9332篇
  2001年   15694篇
  2000年   13568篇
  1999年   15453篇
  1998年   11505篇
  1997年   11603篇
  1996年   10945篇
  1995年   10955篇
  1994年   10324篇
  1993年   10001篇
  1992年   14716篇
  1991年   14656篇
  1990年   15063篇
  1989年   14383篇
  1988年   13155篇
  1987年   12068篇
  1986年   11138篇
  1985年   10804篇
  1984年   8703篇
  1983年   7199篇
  1982年   6560篇
  1981年   6027篇
  1980年   5744篇
  1979年   7848篇
  1978年   6469篇
  1977年   6319篇
  1976年   5838篇
  1975年   5824篇
  1974年   6409篇
  1973年   6319篇
  1972年   6176篇
  1971年   5758篇
  1970年   5170篇
  1969年   5141篇
  1968年   4541篇
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
121.
122.
123.
The difficulty in predicting the consequences of interactions between different cytokine networks has increased with the expansion of the T helper (Th) cell universe and the discovery of numerous B lymphocyte-derived cytokines. Consequently, it is now difficult to conceptualize a straightforward view of the contribution of these disturbances to the pathogenesis of primary Sj?gren's syndrome (SS). Th1 cells, which produce interferon-γ and IL-2, and Th17 cells, which make IL-17 and TNF-α, have been cast in the leading roles of the play. However, the complex role of T-cell subsets in SS is accentuated by the reciprocal effects of Th17 cells and regulatory T cells found in salivary glands of SS patients. Furthermore, B lymphocyte polarization into type-1 B effector (Be1) and Be2 cells and B-cell modulating factors of the TNF family, most notably the B-cell-activating factor (BAFF), and their prominent role in SS are additional complicating factors. Whereas Th17 cells orchestrate autoreactive germinal centers, local BAFF would repress the generation of Th17 cells. Such new insights into interconnected cytokines in primary SS may lead to new treatments for these patients.  相似文献   
124.
125.
Selective diapedesis of Th1 cells induced by endothelial cell RANTES.   总被引:16,自引:0,他引:16  
Differentiated CD4 T cells can be divided into Th1 and Th2 types based on the cytokines they produce. Differential expression of chemokine receptors on either the Th1-type or the Th2-type cell suggests that Th1-type and Th2-type cells differ not only in cytokine production but also in their migratory capacity. Stimulation of endothelial cells with IFN-gamma selectively enhanced transmigration of Th1-type cells, but not Th2-type cells, in a transendothelial migration assay. Enhanced transmigration of Th1-type cells was dependent on the chemokine RANTES produced by endothelial cells, as indicated by the findings that Ab neutralizing RANTES, or Ab to its receptor CCR5, inhibited transmigration. Neutralizing Ab to chemokines macrophage-inflammatory protein-1alpha or monocyte chemotactic protein-1 did not inhibit Th1 selective migration. Whereas anti-CD18 and anti-CD54 blocked basal levels of Th1-type cell adherence to endothelial cells and also inhibited transmigration, anti-RANTES blocked only transmigration, indicating that RANTES appeared to induce transmigration of adherent T cells. RANTES seemed to promote diapedesis of adherent Th1-type cells by augmenting pseudopod formation in conjunction with actin rearrangement by a pathway that was sensitive to the phosphoinositol 3-kinase inhibitor wortmannin and to the Rho GTP-binding protein inhibitor, epidermal cell differentiation inhibitor. Thus, enhancement of Th1-type selective migration appeared to be responsible for the diapedesis induced by interaction between CCR5 on Th1-type cells and RANTES produced by endothelial cells. Further evidence that CCR5 and RANTES play a modulatory role in Th1-type selective migration derives from the abrogation of this migration by anti-RANTES and anti-CCR5 Abs.  相似文献   
126.
127.
128.
129.
130.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号